Clinical Trials Browser

Completed × Hepatitis C, Chronic × Ribavirin × Clear all

NCT02771405 2026-04-13

FRI-STC

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT00375661 2015-09-02

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic